Old Web
English
Sign In
Acemap
>
Paper
>
598P A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC)
598P A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC)
2021
J.-L. Zhao
E. S. Antonarakis
Heather H. Cheng
Daniel J. George
Rahul Aggarwal
Wassim Abida
B. Decker
T. Smart-Curley
Joseph D. Schonhoft
A. Anderson
S. Haywood
E. Riedel
B. Carver
Alexander W. Wyatt
Felix Y. Feng
Karen E. Knudsen
Dana E. Rathkopf
Keywords:
castration resistant
Prostate cancer
Oncology
Enzalutamide
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]